TABLE 2.

The following scores were calculated to assess the rosacea severity at the baseline (T0) and 6 weeks of quarantine (T1)

	All population (N = 36), median (IQR)		Papulo‐pustular patients (N = 23), median (IQR)		Erythemato‐telangiectatic patients (N = 13), median (IQR)
Variables	T0	T1	T0	T1	T0	T1
CEA	2 (0–3)	3 (0–4)***	1 (0‐2)	2 (0–3)**	2 (2–3)	4 (3–4)**
DLQI	7 (5‐8)	10 (9‐11)***	7 (6‐9)	11 (9‐12)***	6 (4‐6)	9 (8–9)***
GFSS	2.5 (0‐4)	4.5 (0‐6)***	2 (0‐3)	3 (0‐5.5)**	4 (3–5)	6 (5‐7)***
IGA	2 (1‐2.25)	3 (2‐4)***	1 (0‐2)	3 (0–3.5)**	2 (2–3)	4 (3–4)**
PSA	2 (0.75‐3)	3 (2‐4)***	1 (0‐2.5)	2 (0–4)**	2 (2–3)	4 (3–4)**

Note: **P value <.01; ***P value <.0001. P values were calculated in comparison with the relative T0.

Abbreviations: CEA, clinician's erythema assessment; DLQI, dermatology life quality index; GFSS, global flushing severity score; IGA, investigator global assessment, IQR, interquartile range; PSA, patient self‐assessment.